Zimmer Biomet Holdings Income taxes receivable decreased by 15.4% to $198.40M in Q4 2022 compared to the prior quarter. Over 2 years (FY 2020 to FY 2022), Income taxes receivable shows relatively stable performance with a -2.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase may indicate overpayment of estimated taxes or the accrual of refundable credits, representing a potential source of near-term cash inflow.
This represents the amount of income tax overpayments or refundable tax credits that the company expects to recover from...
Common for large corporations that manage complex tax filings across multiple jurisdictions.
income_taxes_receivable| Q3 '21 | Q4 '21 | Q3 '22 | Q4 '22 | |
|---|---|---|---|---|
| Value | $314.70M | $326.70M | $234.60M | $198.40M |
| QoQ Change | — | +3.8% | -28.2% | -15.4% |
| YoY Change | — | — | -25.5% | -39.3% |